Form 4 for UNH UnitedHealth Group
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-21 · accession 0000731766-24-000055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-23 | 2024-02-21 | UNH | REX JOHN F | EVP, CFO | A - Grant | $0.00 | +25.0K | 167.6K | +18% | $0 |
| D | 2024-02-23 | 2024-02-21 | UNH | REX JOHN F | EVP, CFO | F - Tax | $521.97 | -8,899 | 160.7K | -5% | -$4.65M |
| D | 2024-02-23 | 2024-02-21 | UNH | REX JOHN F | EVP, CFO | A - Grant | $0.00 | +26.2K | 26.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | A | A | 18,088 | $0.00 | 169,645.02 | D | — | — | (F1) Represents the settlement of Performance Share Awards for the performance period 2021 - 2023. |
| 2 | Common | Common Stock | 2024-02-21 | F | D | 8,899.30 | $521.97 | 160,745.72 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-21 | A | A | 6,897 | $0.00 | 167,642.72 | D | — | — | (F2) The restricted stock units vest at a rate of 25% annually on February 21 from the years 2025 through 2028. |
| 4 | Derivative | Non-Qualified Stock Options (right to buy) | 2024-02-21 | A | A | 26,154 | $0.00 | 26,154 | D | $521.97 · — to 2034-02-21 | 26,154 Common Stock | (F3) The non-qualified stock options vest at a rate of 25% annually on February 21 from the years 2025 through 2028. |